The RM-RM aid to accurately predict survival rates and are used to help guide BLCA patients to choose the appropriate treatment option, and by inhibiting the fatty acid synthesis pathway involved in FASN a potential therapeutic strategy for BLCA is presented. Here, FASN is linked to bladder transitional cell carcinoma.